Workflow
GOFINTECH QUANT(00290)
icon
Search documents
国富量子(00290):华旸退任非执行董事
智通财经网· 2025-09-19 11:35
智通财经APP讯,国富量子(00290)发布公告,华旸先生已于经改期股东周年大会结束时退任非执行董 事。 ...
国富量子(00290) - 董事名单及彼等的角色与职能
2025-09-19 11:31
網址:https://290.com.hk (股份代號:290) GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) 董事名單及彼等的角色與職能 國富量子創新有限公司的董事會(「董事會」)成員載列如下: 執行董事 孫青女士 非執行董事 聶日明博士 李春光先生 獨立非執行董事 陳健生先生 (主席) 趙公直先生 雷美嘉女士 梁金祥博士 董事會已設立下列三個董事委員會。下表載列若干董事會成員於此等董事委員會 中所擔任的職位: | | 董事委員會 審核委員會 | 提名委員會 | 薪酬委員會 | | --- | --- | --- | --- | | 董事會 | | | | | 孫青女士 | | M | M | | 聶日明博士 | | | | | 李春光先生 | | | | | 陳健生先生 | M | C | M | | 趙公直先生 | C | M | C | | 雷美嘉女士 | M | M | M | | 梁金祥博士 | M | M | M | 附註: C ...
国富量子(00290) - (1) 於二零二五年九月十九日举行之经改期股东週年大会投票表决结果及 (...
2025-09-19 11:30
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) 網址:https://290.com.hk (股份代號:290) (1)於二零二五年九月十九日舉行之經改期股東週年大會 投票表決結果 | | | 票數 | | | | --- | --- | --- | --- | --- | | | 普通決議案* | (概約百分比) | | 投票總數 | | | | 贊成 | 反對 | | | 1. | 接受、考慮及採納截至二零二五年三月 | 2,958,252,835 | 0 | 2,958,252,835 | | | 三十一日止年度之經審核綜合財務報表 | (100%) | (0%) | | | | 及本公司董事(「董事」)會報告書與本公 | | | ...
国富量子(00290) - 有关自愿性公告 与金涌投资有限公司之战略合作之补充公告
2025-09-15 10:49
有關 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 (前稱 GoFintech Innovation Limited 國富創新有限公司) (於開曼群島註冊成立之有限公司) 網址:https://290.com.hk (股份代號:290) 自願性公告 與金涌投資有限公司之戰略合作 之補充公告 茲提述國富量子創新有限公司(「本公司」)日期為二零二五年八月二十六日有關(其 中包括)戰略合作之自願性公告(「該公告」)。除另有界定外,本公告所用詞彙與 該公告所界定者具有相同涵義。 本公司謹此向本公司股東及潛在投資者提供有關戰略合作之補充資料。 戰略合作 — RWA代幣化產品及RWA項目 鑒於本公司與金涌投資簽署之戰略合作備忘錄僅構成合作之指示性框架,擬開展 之RWA 代幣化產品及RWA 項目目前仍在考量及評估中。於本公告日期,該等產品 及項目可能包括符合以下條件的 ...
华检医疗午后涨超9% 收购国富量子有望实现协同效应 公司持续推进RWA交易所战略落地
Zhi Tong Cai Jing· 2025-09-05 06:22
Core Viewpoint - Huajian Medical (01931) is acquiring approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, positioning Huajian Medical as the largest single shareholder of Guofu Quantum [1] Group 1 - The acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while its exchange offers a technology platform and trading venue for asset tokenization [1] - Guofu Quantum has strong capabilities in financial technology, providing financial licensing resources, digital asset issuance and trading capabilities, as well as expertise in quantum technology [1] Group 2 - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - This platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1] - The initiative is focused on creating a new type of financial infrastructure [1]
港股异动 | 华检医疗(01931)午后涨超9% 收购国富量子有望实现协同效应 公司持续推进RWA交易所战略落地
智通财经网· 2025-09-05 06:15
Core Viewpoint - Huajian Medical (01931) plans to acquire approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, making Huajian the largest single shareholder of Guofu Quantum after the transaction [1] Group 1: Acquisition Details - The acquisition price for Guofu Quantum shares is approximately HKD 3.142 billion [1] - After the acquisition, Huajian Medical will hold 20.31% of Guofu Quantum's total issued share capital [1] Group 2: Strategic Importance - This acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while Guofu Quantum has strong capabilities in financial technology [1] Group 3: Resource Sharing and Synergy - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - The new platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1]
国富量子拟配发7.45亿股 净筹约13.214亿港元
Core Viewpoint - The company has terminated the original subscription agreement due to unmet conditions and current market conditions, and has entered into a new subscription agreement with 11 subscribers to issue 745 million shares at a discounted price [1] Group 1: Subscription Agreement Details - The original subscription agreement will no longer proceed, and both parties will not seek compensation from each other [1] - A new subscription agreement was signed on September 4, 2025, for a total of 745 million shares, representing approximately 7.57% of the enlarged total share capital [1] - The subscription price is set at HKD 1.78 per share, which is about 16.43% lower than the closing price of HKD 2.13 on September 4 [1] Group 2: Financial Implications - The new subscription is expected to raise approximately HKD 1.3264 billion in total funds, with a net amount of about HKD 1.3214 billion [1]
映宇宙(03700.HK)拟斥资3亿港元折价认购国富量子股份 加码Web3.0生态与金融科技投资
Ge Long Hui· 2025-09-04 22:44
Group 1 - The core point of the announcement is that the company, Yingyu Universe, has entered into a subscription agreement with Guofu Quantum to issue approximately 169 million shares at a subscription price of HKD 1.78 per share, which represents a discount of about 16.43% compared to Guofu Quantum's closing price of HKD 2.13 on the date of the agreement [1][2] - Upon completion of the agreement, the company will hold approximately 169 million shares of Guofu Quantum, which will represent about 1.85% of the total issued shares as of the announcement date and approximately 1.71% of the expanded total issued shares after the subscription [1] - The company views this subscription as a favorable investment opportunity in Guofu Quantum, given the recent market price of its shares [2] Group 2 - Guofu Quantum is recognized as a prominent fintech investment platform in Hong Kong, supported by the Greater Bay Area, and has a strong reputation in cross-border and cross-industry operations, focusing on international markets [2] - Guofu Quantum and its subsidiaries maintain a significant position in the financial services industry in the local Hong Kong market and are aligned with the Hong Kong government's policies to promote digital economic development through strategic investments in fintech [2] - By focusing on technological innovation, Guofu Quantum not only drives its own development but also strengthens Hong Kong's status as a global financial center and contributes to the acceleration of the Web 3.0 ecosystem [2]
映宇宙拟认购国富量子约1.685亿股股份
Zhi Tong Cai Jing· 2025-09-04 22:18
Core Viewpoint - The company, Yingyu Universe, has entered into a subscription agreement with Guofu Quantum, agreeing to issue a total of 168,539,325 subscription shares at a price of HKD 1.78 per share, which is seen as a favorable investment opportunity given the recent market price of Guofu Quantum's shares [1] Company Summary - Guofu Quantum is a well-known financial technology investment platform in Hong Kong, supported by the Greater Bay Area, with a strong reputation in cross-border and cross-industry operations [1] - The company and its subsidiaries maintain a significant position in the financial services industry within the local market [1] - Guofu Quantum is strategically investing in the fintech sector, aligning with the Hong Kong government's initiatives to promote digital economic development [1] Industry Summary - The focus on technological innovation by Guofu Quantum not only drives its own development but also reinforces Hong Kong's status as a global financial center [1] - The company's efforts contribute to accelerating the construction of the Web 3.0 ecosystem [1]
国富量子拟折让约16.43%发行7.45亿股 净筹约13.214亿港元
Zhi Tong Cai Jing· 2025-09-04 17:04
Group 1 - The original subscription agreement has become invalid as the conditions were not met, and the company will not proceed with the original subscription matters [1] - The company and 11 subscribers have entered into 11 independent subscription agreements, conditionally agreeing to issue a total of 745 million subscription shares, representing approximately 7.57% of the enlarged issued share capital [1] - The subscription price is set at HKD 1.78 per share, which is a discount of approximately 16.43% compared to the closing price of HKD 2.13 on September 4 [1] Group 2 - The total amount raised from the subscription is approximately HKD 1.3264 billion, with a net amount of approximately HKD 1.3214 billion [1]